12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Other News

GigaGen, National Institutes of Health, National Science Foundation transplant, autoimmune news

GigaGen received four grants this year from the NIH and NSF worth over $1 million combined to develop and validate its Cell-Seq platform to monitor patients' disease-specific immune activity. The...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >